CLINICAL_TRIALS
research
· 2025-03-05
Clinical Trial Update: The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial at the University of Alabama at Birmingham is evaluating neuroinflammation in Parkinson disease using TSPO-PET imaging; recruitment i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: RECRUITING